Dravet syndrome treatment covered by insurance after 126 days, reducing annual burden from 100 million won to 10 million won

The Ministry of Health and Welfare will provide National Health Insurance coverage for Fintepla oral solution, a treatment for Dravet syndrome. Fintepla oral solution completed insurance listing in 126 days—about half the previous 240 days—under a pilot program that conducts approval, evaluation and negotiations concurrently. The Ministry of Health and Welfare will also newly cover Polivy, a treatment for diffuse large B-cell lymphoma, and expand coverage of Blincyto, a treatment for childhood leukemia.